Inotiv Inc
NOTV2.049USD
+0.129+6.73%
交易中 （美東）報價延遲15分鐘
70.39M總市值
虧損本益比TTM
關於 Inotiv Inc 公司
Inotiv, Inc. 是一家合同研究公司，致力於爲製藥和醫療器械行業提供非臨牀和分析藥物發現和開發服務，並向同一行業以及學術界和政府客戶出售一系列研究級動物和飼料。其產品和服務專注於將新藥和醫療器械帶入發現和臨牀前開發階段。該公司通過兩個部門運營：發現和安全評估 (DSA) 和研究模型和服務 (RMS)。DSA 部門支持研究人員和臨牀醫生對主要小分子候選藥物以及生物治療和生物醫學設備的發現、非臨牀開發和臨牀開發需求。RMS 部門提供一系列用於基礎研究和藥物發現與開發的小型和大型研究模型，以及針對特定疾病和治療領域的專門模型。
公司簡介
公司代碼NOTV
公司名稱Inotiv Inc
上市日期Nov 25, 1997
CEOMr. Robert W. Leasure, Jr.
員工數量1977
證券類型Ordinary Share
年結日Nov 25
公司地址2701 Kent Ave
城市WEST LAFAYETTE
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編47906-1382
電話13174634527
網址https://www.inotiv.com/
公司代碼NOTV
上市日期Nov 25, 1997
CEOMr. Robert W. Leasure, Jr.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
Mr. Brennan Freeman
Mr. Brennan Freeman
Vice President - Finance, Corporate Controller, Principal Accounting Officer
Vice President - Finance, Corporate Controller, Principal Accounting Officer
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Terry Coelho
Ms. Terry Coelho
Independent Director
Independent Director
--
--
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
112.15M
90.21%
Other
7.57M
6.09%
Netherlands
4.60M
3.70%
業務
地區
暫無數據
股東統計
更新時間: 8月1日 週五
更新時間: 8月1日 週五
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
3.76%
Balyasny Asset Management LP
3.70%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Kennedy Capital Management LLC
2.92%
Other
82.34%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
3.76%
Balyasny Asset Management LP
3.70%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Kennedy Capital Management LLC
2.92%
Other
82.34%
股東類型
持股股東
佔比
Investment Advisor
13.71%
Individual Investor
9.68%
Hedge Fund
6.68%
Corporation
3.67%
Investment Advisor/Hedge Fund
3.46%
Venture Capital
0.08%
Research Firm
0.07%
Private Equity
0.06%
Bank and Trust
0.05%
Other
62.53%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
195
12.97M
37.74%
-3.77M
2025Q1
224
12.80M
37.26%
-4.48M
2024Q4
233
12.65M
38.89%
+1.31M
2024Q3
250
7.31M
26.57%
-8.16M
2024Q2
259
7.59M
28.13%
-9.62M
2024Q1
274
9.86M
38.07%
-7.14M
2023Q4
278
8.23M
31.98%
-10.32M
2023Q3
287
9.98M
38.79%
-9.73M
2023Q2
284
11.42M
44.51%
-8.98M
2023Q1
283
15.00M
60.03%
-7.75M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
1.29M
3.76%
+204.53K
+18.80%
Mar 31, 2025
Balyasny Asset Management LP
1.27M
3.7%
-33.79K
-2.59%
Mar 31, 2025
Jermyn Street Associates, L.L.C.
1.26M
3.67%
-118.26K
-8.58%
Apr 03, 2024
Leasure (Robert Jr.)
1.24M
3.62%
+429.73K
+52.90%
Mar 14, 2025
Kennedy Capital Management LLC
1.00M
2.92%
-264.30K
-20.84%
Mar 31, 2025
Sagartz (John E)
708.32K
2.06%
+30.00K
+4.42%
Mar 14, 2025
Hardy (Adrian)
400.78K
1.17%
+25.00K
+6.65%
Mar 14, 2025
Millennium Management LLC
353.18K
1.03%
+65.28K
+22.67%
Mar 31, 2025
Vantage Point Financial, LLC.
336.55K
0.98%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
328.48K
0.96%
+90.63K
+38.10%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Avantis US Small Cap Equity ETF
0%
Avantis US Small Cap Value ETF
0%
Avantis US Equity ETF
0%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
iShares Micro-Cap ETF
佔比0.01%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.01%
Avantis US Small Cap Equity ETF
佔比0%
Avantis US Small Cap Value ETF
佔比0%
Avantis US Equity ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
DFA Dimensional US Core Equity Market ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
